You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
同源康醫藥(02410.HK)非執董於禁售期內出售公司1萬股
阿思達克 08-22 10:32
同源康醫藥(02410.HK)公布,接獲非執行董事顧虹通知,其全資擁有的公司貝沃特醫藥技術(上海)於前日(20日)進行了一項場內交易,售出合共1萬股公司H股股份,代價為每股14.99元,涉資14.99萬元,於轉讓前並無根據上市規則附錄C3第B.8段規定事先告知公司。顧虹H股實益權益股已從約2.20%降至約2.19%。 根據上市規則附錄C3第A.3段,董事於公司財務業績刊發的任何日子及緊接公司截至2025年6月30日止六個月的中期業績刊發日期前30日期間內,以及任何延遲刊發中期業績公告的期間內不得買賣任何公司任何證券。由於是次轉讓處於禁售期內,構成顧虹買賣股份及上市規則附錄C3第A.3及B.8段的違規事件,他已報告違規事件並確認違規乃無心之失,並非蓄意為之,並進一步確認於發生轉讓時並無擁有公司任何內幕消息。 當日該股股價收跌18.7%,報15.32元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account